Victory Capital Management
FLXN

Victory Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Victory Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,332
Closed -$66K – 3596
2020
Q1 		$66K Buy
8,332
+2,271
+37% +$34.2K ﹤0.01% 2664
2019
Q4 		$125K Buy
6,061
+1,546
+34% +$26.1K ﹤0.01% 2472
2019
Q3 		$62K Buy
+4,515
New +$53.6K ﹤0.01% 2594
2016
Q3 		– Sell
-1,214
Closed -$18K – 1857
2016
Q2 		$18K Buy
1,214
+25
+2% +$314 ﹤0.01% 1601
2016
Q1 		$11K Buy
1,189
+93
+8% +$1.13K ﹤0.01% 1647
2015
Q4 		$21K Buy
1,096
+62
+6% +$1.08K ﹤0.01% 1646
2015
Q3 		$15K Buy
1,034
+77
+8% +$1.81K ﹤0.01% 1593
2015
Q2 		$21K Buy
+957
New +$19.3K ﹤0.01% 1590

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return